Hereditary Breast and Ovarian Cancer Syndrome
"Hereditary Breast and Ovarian Cancer Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autosomal dominant HEREDITARY CANCER SYNDROME in which a mutation most often in either BRCA1 or BRCA2 is associated with a significantly increased risk for breast and ovarian cancers.
| Descriptor ID |
D061325
|
| MeSH Number(s) |
C04.588.180.483 C04.588.322.455.431 C04.700.517 C13.351.500.056.630.705.431 C13.351.937.418.685.431 C16.320.700.517 C17.800.090.500.483 C19.344.410.431 C19.391.630.705.431
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hereditary Breast and Ovarian Cancer Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Hereditary Breast and Ovarian Cancer Syndrome".
This graph shows the total number of publications written about "Hereditary Breast and Ovarian Cancer Syndrome" by people in this website by year, and whether "Hereditary Breast and Ovarian Cancer Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hereditary Breast and Ovarian Cancer Syndrome" by people in Profiles.
-
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes. Am J Hum Genet. 2025 Dec 04; 112(12):2902-2921.
-
Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions. J Genet Couns. 2022 10; 31(5):1062-1070.
-
First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women. Int J Cancer. 2021 06 15; 148(12):2964-2973.
-
Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study. Clin Genet. 2019 02; 95(2):293-301.